Dr. James Thomas Boyd, MD

Dr. Boyd practices at University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network.

Dr. Boyd's NPI, 1922021088, was assigned on July 26, 2006. Dr. Boyd holds Vermont license 0420010882.

Dr. Boyd's primary practice is University of Vermont Medical Center, at 111 Colchester Ave, Burlington, VT 05401 in Chittenden County. The practice phone is (802) 847-0000.

Dr. Boyd's primary practice is University of Vermont Medical Center in Burlington, Vermont, part of University of Vermont Health Network. Dr. Boyd is also affiliated with Northwestern Medical Center. The medical group on file is University of Vermont Medical Center. Dmand AI also links Dr. Boyd to 1 more hospital, 1 dialysis center and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boyd practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Boyd's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Boyd is licensed in Vermont.

CMS data shows 1,017 Medicare services from Dr. Boyd across 14 procedure codes in 2024, for 300 Medicare patients. Medicare paid $58,553 for them.

CMS counts 300 Medicare patients who saw Dr. Boyd in 2024. The largest group is 65 to 74, with 124 patients. 52% of them have high cholesterol, and 50% have high blood pressure. 25% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Boyd's median patient age at 74, with 47% women.

In 2024, Dr. Boyd wrote 2,890 Medicare Part D claims for 255 patients. 83% of them were for generic drugs. CMS names the drug for 2,614 of them, across 56 drugs with 11 or more claims each, at $1,611,069 in total drug cost. In 2023, CMS named 2,548 claims across 54 drugs.

Dr. Boyd accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Boyd as offering telehealth.

Dmand AI links 11 papers to Dr. Boyd, published from 2011 to 2020. 2016 was the busiest year, with 4. The most frequent topics are Gene Expression Regulation and Single-Cell Analysis. Dr. Boyd's most frequent co-authors are Rachelle S. Doody, MD, PhD, Robert A. Hauser, MD and Geoffrey Allen Kerchner, MD, PhD.

CMS Open Payments shows 50 general payments to Dr. Boyd from 6 drug and device companies from 2016 to 2023. Consulting fees make up the largest share, 81% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $8,860. It also lists 4 research payments totaling $752 from 2017 to 2021.